News Focus
News Focus
icon url

hoffmann6383

10/12/22 3:31 PM

#521414 RE: vator #521410

My thoughts would be NWBO was working with Flaskworks since 2014.



What?! NWBO purchased Flaskworks in August of 2020. Another bullshit narrative that attempts to put management in a negative light (surprise surprise).

Have a great one Vator.
icon url

HappyLibrarian

10/12/22 3:36 PM

#521420 RE: vator #521410

So they can own it all, but if it is so so slow out the door, they have hurt shareholders and sooner or later competitors will be plentiful. I am not privileged to all information but they sure give very little out.



As good an explanation as any, especially when you factor in the Woodford affair. Ms. Powers is willing to pay any price or more aptly make shareholders and even patients pay any price to retain total control of DCVax-L and Direct. We see the worst cost every time we get a request for information related to a newly diagnosed case.
icon url

biosectinvestor

10/12/22 3:40 PM

#521422 RE: vator #521410

Nonsense, if it was “so slow out the door” that would mean there are a lot of companies with similar technology breathing down their neck, which is not the case. This is a one of a kind total technology set and no one else has anything else approaching it in sophistication. There are other ways of doing other things, that does not make them slow, there will always be a range of technologies just like there are people advancing electric cars and hydrogen cars. Different technologies but both may have a place. I expect this will have a very useful and important place in the technology tool bag and will be ready sooner for a wider range of cancers than some other ideas that will require case by case validation.
icon url

iwasadiver

10/12/22 3:45 PM

#521428 RE: vator #521410

When you believe you have a platform for the entire set of all solid Cancers, and look beyond to anti virals and even more, you don’t partner with someone who wants to steal the whole thing. As far as timing goes what shareholders got hurt and when? Anyone with any vision and good investigative skills in biotech, let alone the drama that went on after 2015, would have loaded up at .14 cents and would be way ahead of the game now and be calm and accommodating.

NWBO has not made any claims to a timeline since making the statement they “hoped’ to have TLD before the end of September 2020. Even then, if you look deep and think straight without emotion, one would see Stupp became an advisor just after LP said that. One should be able to start putting 2 and 2 together at that point and then look at how outside comparators need to be vetted with individual patient data; all being collected and verified during a global pandemic. I believe weak hands freak out because they have no clue what they’re into and when their family or friends start giving them shit for the promises they made, not the company, it turns into a junior high school gossip fest of blame and shame.

Yeah, it took longer. But nobody has as much skin in the game as LP and LG.

And FlaskWorks came to NWBO’s attention only around mid to late 2019. I happen to know a bit about this from outside conversations with someone in Europe as this was occurring. I’ve talked to Mike Scott and with Dr. Murthy; they pulled this together really quickly and the purchase announcement was made in Sept. 2020. Mike Scott is a genius and anything that’s been approved or scheduled regarding manufacturing has been done as expedient as anyone could have.

When you have one product and 100’s of boxes to check and tasks to perform that rely a lot on outside contractors, transportation elements, regulators, supply chain logistics, etc. every little delay appears much greater. I’ve walked in those shoes and taken the heat many times. I guarantee the ends have always justified the means and when the final reveal occurs and the client, or the patient, or the partner sees the worth of what they waited for all is forgiven in a New York minute. The celebration always obscures the pain of the wait